Healthcare provider profile · identity verified

Daniel Curtin, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · WAYLAND, NY · NPI 1497709737

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel Curtin, M.D. received $37.72 in general payments during 2025 across 2 reported records.

Dexcom, Inc. accounted for 52.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$37.72

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$19.86	52.6%	1	2025
BETA BIONICS, INC.	Unresolved — no canonical attribution shown	$17.86	47.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$37.72	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$19.86	1	2025
Source payment records 2025-02-12 · Dexcom, Inc. · $19.86 · Open Payments source
iLet Bionic Pancreas Normalized: ilet bionic pancreas	Device	BETA BIONICS, INC.	$17.86	1	2025
Source payment records 2025-05-09 · BETA BIONICS, INC. · $17.86 · Open Payments source
iLet Insulin Infusion Kit Contact Detach Normalized: ilet insulin infusion kit contact detach	Device	BETA BIONICS, INC.	$17.86	1	2025
Source payment records 2025-05-09 · BETA BIONICS, INC. · $17.86 · Open Payments source
iLet Insulin Infusion Kit Inset Normalized: ilet insulin infusion kit inset	Device	BETA BIONICS, INC.	$17.86	1	2025
Source payment records 2025-05-09 · BETA BIONICS, INC. · $17.86 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	158
Lisinopril	Lisinopril	492	129
Amlodipine Besylate	Amlodipine Besylate	454	128
Levothyroxine Sodium	Levothyroxine Sodium	442	111
Omeprazole	Omeprazole	442	109
Rosuvastatin Calcium	Rosuvastatin Calcium	375	91
Gabapentin	Gabapentin	345	88
Pantoprazole Sodium	Pantoprazole Sodium	330	89
Losartan Potassium	Losartan Potassium	293	75
Metformin Hcl	Metformin Hcl	251	69
Metoprolol Succinate	Metoprolol Succinate	250	75
Hydrochlorothiazide	Hydrochlorothiazide	243	66
Albuterol Sulfate Hfa	Albuterol Sulfate	232	66
Furosemide	Furosemide	221	59
Meloxicam	Meloxicam	205	46
Prednisone	Prednisone	203	97
Metoprolol Tartrate	Metoprolol Tartrate	176	44
Eliquis	Apixaban	174	37
Atenolol	Atenolol	165	42
Tamsulosin Hcl	Tamsulosin Hcl	165	47
Oxycodone Hcl	Oxycodone Hcl	141	20
Famotidine	Famotidine	135	40
Simvastatin	Simvastatin	132	35
Ezetimibe	Ezetimibe	130	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	12
Metformin Hcl Er	Metformin Hcl	127	29
Allopurinol	Allopurinol	123	36
Alendronate Sodium	Alendronate Sodium	121	25
Sertraline Hcl	Sertraline Hcl	117	28
Trazodone Hcl	Trazodone Hcl	117	20
Clopidogrel	Clopidogrel Bisulfate	115	29
Ozempic	Semaglutide	115	17
Montelukast Sodium	Montelukast Sodium	101	24
Warfarin Sodium	Warfarin Sodium	100	20
Fluoxetine Hcl	Fluoxetine Hcl	98	21
Fluticasone Propionate	Fluticasone Propionate	98	32
Zolpidem Tartrate	Zolpidem Tartrate	98	15
Alprazolam	Alprazolam	96	26
Duloxetine Hcl	Duloxetine Hcl	95	25
Finasteride	Finasteride	91	23
Methylprednisolone	Methylprednisolone	91	41
Escitalopram Oxalate	Escitalopram Oxalate	89	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	24
Clonazepam	Clonazepam	87	14
Torsemide	Torsemide	82	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	82	19
Doxycycline Hyclate	Doxycycline Hyclate	81	64
Potassium Chloride	Potassium Chloride	80	24
Bupropion Xl	Bupropion Hcl	78	20
Venlafaxine Hcl Er	Venlafaxine Hcl	77	19
Citalopram Hbr	Citalopram Hydrobromide	75	18
Irbesartan	Irbesartan	73	16
Spironolactone	Spironolactone	72	21
Methotrexate	Methotrexate Sodium	71	17
Carvedilol	Carvedilol	70	16
Lorazepam	Lorazepam	68	19
Oxybutynin Chloride Er	Oxybutynin Chloride	68	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	14
Glipizide Er	Glipizide	65	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	13
Paroxetine Hcl	Paroxetine Hcl	56	14
Xarelto	Rivaroxaban	51	13
Chlorthalidone	Chlorthalidone	49	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	16
Fenofibrate	Fenofibrate,micronized	48	13
Januvia	Sitagliptin Phosphate	48	12
Jardiance	Empagliflozin	46	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	11
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Topiramate	Topiramate	45	12
Lamotrigine	Lamotrigine	44	suppressed
Mirtazapine	Mirtazapine	44	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	38
Pregabalin	Pregabalin	42	12
Baclofen	Baclofen	41	suppressed
Glimepiride	Glimepiride	41	13
Terazosin Hcl	Terazosin Hcl	41	suppressed
Azithromycin	Azithromycin	40	35
Cephalexin	Cephalexin	40	26
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Tramadol Hcl	Tramadol Hcl	38	12
Hydroxyzine Hcl	Hydroxyzine Hcl	36	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Ibuprofen	Ibuprofen	34	15
Enalapril Maleate	Enalapril Maleate	33	suppressed
Risperidone	Risperidone	32	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Carbidopa-Levodopa Er	Carbidopa/Levodopa	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	28
Fluconazole	Fluconazole	27	15
Glipizide	Glipizide	27	suppressed
Mupirocin	Mupirocin	27	12
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	15
Synthroid	Levothyroxine Sodium	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	20
Invokana	Canagliflozin	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Prolia	Denosumab	23	14
Amoxicillin	Amoxicillin	22	16
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Oxycontin	Oxycodone Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	21	suppressed
Methimazole	Methimazole	21	suppressed
Nitroglycerin	Nitroglycerin	21	15
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Fluocinonide	Fluocinonide	20	13
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Testosterone	Testosterone	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Estradiol	Estradiol	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Metronidazole	Metronidazole	15	13
Unifine Pentips	Pen Needle, Diabetic	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Praluent Pen	Alirocumab	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Zestril	Lisinopril	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Budesonide Ec	Budesonide	11	suppressed
Klor-Con	Potassium Chloride	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$37.72 · 2 records	Dexcom, Inc.	Dexcom G6 Transmitter, iLet Bionic Pancreas, iLet Insulin Infusion Kit Contact Detach, iLet Insulin Infusion Kit Inset	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error